Speaker illustration

Doctor Manuel Marina Breysse

Idoven, Madrid (Spain)

Dr. Manual Marina Breysse CHIEF EXECUTIVE OFFICER AND CO-FOUNDER, IDOVEN Dr. Manuel Marina Breysse is a cardiologist, CEO and co-founder of Idoven, a European deep tech company advancing artificial intelligence for cardiovascular diseases. Manuel and his co-founders started Idoven in 2018 after conducting basic and translational research since 2014 at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Spain focused on machine learning applied to cardiology. As a scientist, Manuel is specialized in signal processing, arrhythmias and sports cardiology. He has been a doctor at the Spanish Agency for Health Protection in Sports (AEPSAD). He is also a member of the ESC, an Associate Partner of the Spanish Society of Cardiology, and scientist at the Cardiovascular Disease Network Biomedical Research Center (CIBERCV). Manuel has published relevant scientific papers, received a MS in Statistics from the University of Cordoba and MD from the University of Alcalá.

Clinical events after percutaneous coronary intervention depending on dual antiplatelet therapy cessation

Event: Acute Cardiovascular Care 2016

Topic: Antithrombotic agents

Session: Antithrombotic therapy

Thumbnail

Treatment cessation of dual antiplatelet therapy after percutaneous coronary intervention and clinical events during follow-up

Event: EuroPRevent Meeting 2016

Topic: Cardiac rehabilitation, models and methods

Session: Posters Group 2

Thumbnail